Fortrea
Dana Glisson currently serves as the Vice President and Global Head of Site Readiness and Regulatory at Fortrea since July 2023. Prior to this role, Dana held the position of Global Head of Site Readiness and Regulatory at Labcorp Drug Development from January 2023 to August 2023. Dana's extensive experience includes serving as the Regional Vice President of Clinical Operations for the Americas and Executive Director, Head of North America Clinical Operations at Covance from February 2018 to January 2023. Dana's career began at Quintiles, where responsibilities included Senior Director, Director, Associate Director, and Manager of Access to Patients from November 2007 to January 2018.
This person is not in any teams
This person is not in any offices
Fortrea
13 followers
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.